The economy remains the foundation of the competition. The U.S. leads in nominal GDP; China leads in purchasing power parity. China's officially reported ~5% growth in 2024 almost certainly overstates the real figure — Beijing has strong incentives to hit targets on paper. China's trade surplus hit a record $1.2 trillion in 2025, a sign of industrial overcapacity driving export pressure on the rest of the world.
Nominal GDP (2026 proj., USD)
$32.4T US
$21.3T China
US leads 1.52× · IMF Apr 2026
GDP PPP (2026 proj.)
$32.4T US
$44.3T China
China leads in PPP · IMF Apr 2026
GDP growth (2024, official)
2.8% US
~5.0% China
China figure likely overstated
Trade surplus (2025)
Deficit US
$1.2T China
Record Chinese surplus · CSIS 2025
GDP nominal (USD trillions)
United StatesChina
Source: IMF World Economic Outlook, April 2026 · Update every 6 months
GDP purchasing power parity (USD trillions)
PPP adjusts for cost-of-living differences across countries and is widely considered the best measure for comparing the actual size of economies. By this measure China has led the U.S. since 2014.
United StatesChina
Source: IMF World Economic Outlook, April 2026 · Update every 6 months
GDP per capita nominal (USD)
United StatesChina
Whatever China's total economy size, its people remain far less wealthy on average. GDP per capita is often the most meaningful individual welfare measure.
Source: IMF · Update every 6 months
GDP growth rate (%, officially reported)
China's growth figures are widely considered overstated. Take them with a large grain of salt.
United StatesChina
Source: IMF WEO April 2026 · Update quarterly
Trade balance ($B goods + services)
US balanceChina surplus
Source: WTO / CSIS 2025 · Update quarterly
Artificial intelligence new
AI is arguably the most consequential technology competition of this era. The U.S. leads in private investment, frontier model performance, and research influence. China leads in patent volume, publication counts, and industrial deployment speed. The quality gap that stood at double-digits on major benchmarks in 2023 had essentially closed by end-2024 — the Stanford AI Index 2026 puts the current U.S. performance lead at just 2.7%.
China's enormous state-directed AI funding — estimated at $184 billion in government guidance funds through 2023, plus a new $138 billion state VC fund announced in 2025 — is largely invisible in private investment comparisons. The private investment gap is real but overstated as a measure of total resource mobilization.
🇺🇸 United States
Metric
China 🇨🇳
$285.9B leads
Private AI investment (2025)
$12.4B
50 models leads
Notable AI models (2025)
30 models ↑ fast
12.1%
Share of global AI patents
74.2% leads
7.3%
Share of AI research papers
17.8% leads
51.9% leads
Share of AI patent forward citations
lower quality
13.18 avg leads
Citations per AI patent
1.90 avg
1,953 leads
New AI companies funded (2025)
161
+2.7% lead
Top model benchmark margin
Was –17.5% in 2023 ↑ fast
Private AI investment (USD billions)
Note: excludes China's estimated $184B+ in state guidance funds deployed through 2023.
United StatesChina
Source: Stanford AI Index 2026 / Quid · Update annually
U.S. benchmark lead over China (percentage points)
The collapse from double-digit gaps to near-parity in one year is the defining data point of the AI competition.
Source: Stanford AI Index 2025/2026 · Update annually
Notable AI models released per year
United StatesChina
Source: Stanford AI Index 2026 / Epoch AI · Update annually
AI patent filings (thousands, annual)
China leads massively in volume; U.S. patents are cited nearly 7× more often, reflecting higher quality and commercial impact.
Beyond AI, the competition spans multiple dual-use and economically critical technologies. China leads in 53 of 64 key strategic technologies tracked by Australia's ASPI, including 5G, EV production, battery manufacturing, and industrial robotics. The U.S. leads in the 11 areas that include quantum computing, genetic engineering, and advanced aerospace. In most areas China leads in volume; the U.S. in quality and commercial value.
Semiconductor foundry market share (Q3 2025)
China's SMIC grew 70% in revenue since 2022 despite U.S. export controls, but remains generations behind TSMC on advanced nodes. U.S.-designed chips (Nvidia, Apple, AMD) run on TSMC fabs in Taiwan.
China leads in 5G/6G, EVs, batteries, solar, drones, and synthetic biology. U.S. leads in quantum computing, genetic engineering, and aerospace. In battery research, China publishes 65% of all high-impact papers; U.S. 12%.
China installed 54% of all global industrial robots in 2024 — more than the rest of the world combined.
Source: IFR World Robotics 2025 · Update annually
Clean tech manufacturing global market share (China, %)
China controls over 70% of global manufacturing capacity in every major clean-tech segment. Clean energy patents: China 75% of global applications (up from 5% in 2000).
Source: BloombergNEF / IEA / Ember 2025 · Update annually
Quantum computing: where each country leads
🇺🇸 US position
Subfield
China 🇨🇳 position
Leads advantage
Gate-based computing (Google, IBM)
Competitive, closing
Competitive
Quantum communications
Leads deployed national network
Leads advantage
Private investment & ecosystem
State-led funding
Strong
Quantum sensing
Closing fast (2024–25)
In March 2025, China's "Zu Chongzhi III" set a new quantum supremacy record in superconducting systems. China has deployed the world's largest operational quantum secure communications network. The U.S.-China Economic and Security Review Commission 2025 warned that "whoever leads in quantum will control encryption of the digital economy."
The U.S. outspends China on defense by roughly 3-to-1 at official exchange rates, but the gap is meaningfully smaller in purchasing power terms — China's lower labor and procurement costs stretch its budget further. More importantly, China's military is optimized for a specific geography: defeating U.S. forces in the Western Pacific. China's nuclear arsenal is growing faster than any other nation. Its space and cyber capabilities have been described by U.S. military leaders as advancing at a "breathtaking" pace.
China's official defense budget ($246B in 2025) understates real spending by 40–90%, according to the U.S. Department of Defense. SIPRI estimates actual spending at $336B in 2025. Real purchasing-power-adjusted estimates range from $450B to $700B+, though these are contested. The U.S. spent $954B in 2025 (SIPRI), down slightly due to reduced Ukraine aid, but Congress approved over $1 trillion for 2026.
Defense spending (SIPRI 2025)
$954B US
$336B China
US leads ~3× · SIPRI Apr 2026
Nuclear warheads (est. 2025)
~3,700 US
~600 China
China → 1,000+ by 2030 · FAS/DoD
Aircraft carriers (active)
11 US
3 China
China targeting 9 by 2035 · DoD
Annual spending growth
declining
31st year ↑ in a row
China up 7.4% in 2025 · SIPRI
Defense spending (SIPRI estimates, $B)
United StatesChina
Source: SIPRI Military Expenditure Database, April 2026 · Update annually
China's nuclear warhead expansion
China added 100 warheads in 2024 alone. It is the fastest-growing nuclear arsenal in the world. The DoD projects China will reach 1,000+ warheads by 2030 and ~1,500 by 2035, approaching parity with U.S. deployed forces.
Source: Federation of American Scientists / DoD China Military Power Report 2024 · Update annually
Drone manufacturing new
Drones are the most visible lesson of modern warfare: Ukraine has shown that mass-produced, cheap, attritable UAVs can inflict decisive damage and reshape battlefields. China dominates this competition utterly — in commercial, industrial, and increasingly military drone production. DJI alone builds millions of drones per year. The ~500 U.S. drone manufacturers combined produce fewer than 100,000 annually. This is not a gap — it is a chasm, and it has direct military implications.
China controls 90% of the consumer drone market, 70%+ of the enterprise market, and 92% of the U.S. state and local first responder market (AUVSI 2024). Nearly every U.S. "domestic" drone startup still depends on Chinese-made components — airframes, batteries, motors, cameras. The U.S. Army Secretary acknowledged in 2025 that the Army buys ~50,000 drones/year and needs to reach "half a million to millions" — but questioned whether U.S. industry can deliver at that scale.
Annual drone production
<100K US
Millions+ China
DJI alone: millions/yr · AUVSI 2024
Commercial drone market share
small fraction US
70–90% China
DJI ~70% alone · AUVSI / SCSP 2024
Drone patent share (2024)
—
79% China
Of all approved drone patents · 2024
Annual drone exports (China)
—
~40M units
incl. 600K to US · Quasa 2025
Estimated annual drone production (units, thousands)
United States (all ~500 manufacturers combined)China (DJI alone)
Scale caveat: China's figure is DJI's estimated output alone, in millions. The U.S. figure is the combined output of approximately 500 companies, in thousands. The U.S. leading drone company, Skydio, had built a cumulative 45,000 drones total by mid-2025 — a quantity DJI produces in a few weeks.
Source: AUVSI / Morgan Stanley / NYT July 2025 · Update annually
Commercial drone market share (%, 2024)
The security implications are significant: DJI drones are used by U.S. police departments, first responders, farmers, and federal agencies. Chinese companies are legally required to provide data access to the Chinese government on request (2017 National Intelligence Law).
Military and economic power don't automatically translate into global influence. This section tracks diplomatic networks, soft power, and how third countries perceive and align with each superpower. The headline: China has surpassed the U.S. in raw diplomatic footprint, but the U.S. retains a large lead in soft power and alliance networks. U.S. favorability has fallen significantly in the early Trump second term.
Diplomatic posts worldwide (2024)
271 US
274 China
China #1 overall · Lowy 2024
Global Soft Power Index (2026)
#1 US (74.9)
#2 China (73.5)
Near parity · Brand Finance 2026
Formal military alliances
NATO + 50+ US
None formal China
US enormous structural advantage
Foreign military bases
~750+ US
~5 China
US dominant globally · DoD 2024
Diplomatic posts by region (2024)
United StatesChina
Source: Lowy Institute Global Diplomacy Index 2024 · Update annually
Global Soft Power Index score (higher = more soft power)
United StatesChina
The U.S. temporarily lost its #1 soft power ranking during Trump's first term and has seen a new decline post-2025. China has risen faster than any other country in the index over 5 years.
Source: Brand Finance Global Soft Power Index · Update annually
Critical minerals & supply chains new
This is one of China's most decisive and underappreciated strategic advantages. China dominates the processing and refining of nearly every critical mineral required for clean energy, electric vehicles, semiconductors, and advanced defense systems. The U.S. is 100% import-reliant for 12 critical minerals and over 50% reliant for 29 others. China has already weaponized this — restricting exports of gallium, germanium, rare earths, and battery materials in response to U.S. chip export controls.
China's share of global critical mineral processing (%, 2024)
In December 2024, China restricted exports of gallium, germanium, and antimony. In early 2025, it added tungsten, rare earths, and battery materials. These are not hypothetical vulnerabilities — they are active weapons.
The U.S. has vast mineral resources but permitting timelines of up to 20 years have prevented rapid development. The Trump administration opened a $1B funding line for critical mineral processing in August 2025.
Source: USGS 2025 / Resources for the Future 2025 · Update annually
Biotechnology new
The U.S. remains the global biotech leader by most measures — market share, new drug development, CRISPR commercialization, and mRNA platform development. But China is closing fast, and in specific areas has already overtaken the U.S. China's WuXi AppTec has become so embedded in global pharmaceutical supply chains that 79% of U.S. biopharma companies depend on it for at least some manufacturing. China also overtook the U.S. in oncology clinical trials in 2024.
Biotech market share (2024)
35% US
4.8% China
US dominant · EU 31% · CKGSB 2024
Oncology clinical trials (2024)
32% US
39% China leads
China overtook US in 2024 · Cora
Biopharma R&D spending growth
steady
400× increase vs decade ago
China's explosive scaling · NSCEB
Genomic data assets
strong
largest in world
China National GeneBank · growing
Global biotech market share (2024)
The U.S. still dominates in commercialization. In 2014–2018, U.S. firms produced nearly 4× as many new drug entities as Japan and twice as many as Europe. But China's "fast-follow" strategy is generating an increasing share of globally licensed innovations.
Source: CKGSB / ITIF / European think tank estimates 2024 · Update annually
10 of the top 15 commercial CRISPR patent assignees are U.S.-based. Chinese and U.S. academic institutions are more evenly matched (9:6 ratio). The first CRISPR therapy (Casgevy) was approved in November 2023 by U.S./EU regulators.
China remains the world's largest CO2 emitter by a wide margin — but is simultaneously the world's dominant clean energy investor and manufacturer. It hit its 2030 renewables capacity target six years early and accounts for 31% of all global clean energy investment. The U.S. is now rolling back clean energy programs as China doubles down. This section may be where China's long-term positioning looks strongest.
Annual CO2 emissions (billion tonnes)
United StatesChina
Source: Global Carbon Project / Our World in Data · Update annually
Clean energy investment (USD billions)
United StatesChina
China's clean energy investment in 2024 was $625B — 31% of the global total. U.S. trajectory now uncertain after 2025 IRA rollbacks.
Source: IEA World Energy Investment 2025 · Update annually
Social
The U.S. has serious self-inflicted wounds here — life expectancy has converged with China's after years of opioid deaths and COVID aftereffects, press freedom has declined, and happiness rankings have slipped. China continues to restrict its own people in ways that represent a long-term strategic liability: governments afraid of their own citizens are governments with fundamental legitimacy problems.
Life expectancy (years at birth)
United StatesChina
China has now overtaken the U.S. in life expectancy — a remarkable reversal. Opioids, COVID, and structural health inequality have driven U.S. life expectancy to historic lows.
Source: World Bank / UN Population Division 2024 · Update annually
Press freedom rank (lower = more free, out of ~180 countries)
United StatesChina
China remains one of the most repressive press environments on earth. The U.S. fell to 55th in 2024, its worst ranking in years — a self-inflicted decline.
Source: Reporters Without Borders 2024 · Update annually
World Happiness Report rank (lower = happier)
United StatesChina
Source: World Happiness Report 2024 · Update annually
Global Innovation Index rank (lower = more innovative)
United StatesChina
Source: WIPO Global Innovation Index 2024 · Update annually
State capacity
The U.S. still scores better on standard governance quality metrics, but China's capacity to execute on strategic industrial goals is genuinely formidable. R&D: the U.S. spent an estimated 3.4% of GDP in 2024 ($993B total), holding its lead, but China is closing — reaching 2.68% in 2024 and 2.80% in 2025, exceeding the OECD average for the first time. China's R&D spending grew at an average of 10.5% annually from 2021–2024, one of the fastest rates among major economies.
R&D spending (% of GDP)
United StatesChina
China's 2025 R&D intensity of 2.80% exceeded the OECD average for the first time. US 2024 figure is NSF estimate; 2025 not yet reported. China 2023 revised down to 2.58% from initial 2.64% per NBS GDP revision.
Source: NSF NCSES Feb 2026 (US) / NBS China Sep 2025 / OECD MSTI · Update annually
World Bank government effectiveness (percentile)
United StatesChina
Source: World Bank Governance Indicators 2023 · Update annually
Demographics
Demographics remain one of China's most serious long-term vulnerabilities. China's population is now officially shrinking and its fertility rate has collapsed to 1.09 births per woman — the lowest among major nations. The U.S. maintains an advantage through immigration, though that advantage is under increasing policy pressure. In the long run, the country that can attract and retain talent from around the world will have a structural advantage.
Fertility rate (2023)
1.62 US
1.09 China
Both below replacement (2.1) · World Bank
Migrant stock (% of population)
15.3% US
0.1% China
Massive US advantage · UN 2024
Population (2024)
340M US
1,409M China
China population now shrinking · NBS
Working-age pop. trend
Stable US
Declining China
China peaked 2012 · World Bank
Total fertility rate (births per woman)
United StatesChina
China's fertility rate of 1.09 is catastrophically low. Both countries are below replacement level, but China's trajectory is far more severe.
Source: World Bank / NBS China 2024 · Update annually
International students hosted (thousands)
United StatesChina
The U.S. hit a record 1.18 million international students in 2024/25 — but an early 2025/26 snapshot shows a 1% decline and new enrollments down 17%, the first drop after four years of post-pandemic growth. Visa uncertainty and immigration policy are the primary drivers. China's numbers remain well below pre-COVID levels.
Source: IIE Open Doors 2025 (Nov 2025) / UNESCO · Update annually
This index was created by Gittes Global / Sam Kaplan, author of Challenging China. Data sourced from IMF, SIPRI, Stanford AI Index, IEA, SIPRI, World Bank, Lowy Institute, ASPI, WIPO, and others as noted. Have a suggestion? Email us.
